An Exceedingly Rare Case of Liraglutide-Induced Liver Injury. (23rd August 2021)

• Record Type: Journal Article
• Authors: Parvataneni, Swetha; Ramachandran, Rajarajeshwari; Then, Eric; Grantham, Tyler; Gaduputi, Vinaya
• Other Names: Machado Marcel Cerqueira Cesar Academic Editor.
• Is Part Of: Case reports in gastrointestinal medicine. Volume 2021(2021)
• Publication Date: 2021-08-23
• Subjects: Gastroenterology -- Case studies -- Periodicals; Digestive organs -- Diseases -- Periodicals; Gastroenterology; Gastrointestinal Diseases; Digestive organs -- Diseases; Gastroenterology; Electronic journals; Periodicals; Case studies; Periodicals; 616.33
• DOI: 10.1155/2021/6306149
• Languages: English
• ISSNs: 2090-6528

Abstract

Abstract : Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.